Drawing for DR. HANGOVER

USPTO serial 87957326

DR. HANGOVER

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
BAL, KAMAL SINGH
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with DR. HANGOVER?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Robert L. Brewer

Robert L. Brewer BASS, BERRY & SIMS PLC150 3RD AVENUE SOUTHSUITE 2800NASHVILLE, TN 37201

Goods and services

ClassDescriptionStatusFirst use
005Dietary SupplementsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Feb 28, 2022MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Feb 28, 2022ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Aug 19, 2021CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Aug 19, 2021TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Aug 19, 2021EWAFTEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS—
Aug 19, 2021ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 19, 2021REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Aug 19, 2021COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
May 18, 2021EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
May 17, 2021EX5GSOU EXTENSION 5 GRANTED—
May 17, 2021AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
May 6, 2021EXT5SOU EXTENSION 5 FILED—
May 6, 2021EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jan 16, 2021EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jan 14, 2021EX4GSOU EXTENSION 4 GRANTED—
Jan 14, 2021EXT4SOU EXTENSION 4 FILED—
Jan 14, 2021EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jul 23, 2020EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jul 21, 2020EX3GSOU EXTENSION 3 GRANTED—
Jul 21, 2020EXT3SOU EXTENSION 3 FILED—
Jul 21, 2020EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jan 11, 2020EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jan 9, 2020EX2GSOU EXTENSION 2 GRANTED—
Jan 9, 2020EXT2SOU EXTENSION 2 FILED—
Jan 9, 2020EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jul 12, 2019EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jul 10, 2019EX1GSOU EXTENSION 1 GRANTED—
Jul 10, 2019EXT1SOU EXTENSION 1 FILED—
Jul 10, 2019EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jan 22, 2019NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Nov 27, 2018NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Nov 27, 2018PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Nov 7, 2018NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Oct 25, 2018PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Oct 21, 2018ALIEASSIGNED TO LIE—
Oct 5, 2018CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Oct 5, 2018XAECEXAMINER'S AMENDMENT ENTERED—
Oct 5, 2018GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Oct 5, 2018GNEAEXAMINERS AMENDMENT E-MAILED—
Oct 5, 2018CNEAEXAMINERS AMENDMENT -WRITTEN—
Sep 26, 2018DOCKASSIGNED TO EXAMINER—
Jun 16, 2018NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jun 14, 2018NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance